|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/428 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| C07D 277/82 | (2006.01) | ||
| A61K 31/428 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07D 277/82 | (2013.01) |
| (11) | Number of the document | 3458054 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17800311.7 |
| Date of filing the European patent application | 2017-05-19 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/033690 |
| Date | 2017-05-19 |
| (87) | Number | WO 2017/201502 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 201662339433 P | 2016-05-20 | US |
| (72) |
CORIC, Vladimir , US
|
| (73) |
Biohaven Pharmaceutical Holding Company Ltd. ,
234 Church Street
Suite 301, New Haven, CT 06520,
US
|
| (54) | USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER |
| USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER |